Am J Transplant, Volume 21, Suppl 3 Archives - Page 70 of 139 - ATC Abstracts

2021 American Transplant Congress
Better Dialysis Facility Five-Star Rating is Associated with Increased Listing for Kidney Transplantation
J. T. Adler¹, L. Xiang¹, J. S. Weissman¹, J. R. Rodrigue², R. E. Patzer³, S. S. Waikar⁴
¹Surgery, Brigham and Women's Hospital, Boston, MA, ²Surgery, Beth Israel Deaconess Medical Center, Boston, MA, ³Surgery, Emory University, Atlanta, GA, ⁴Medicine, Boston Medical Center, Boston, MA
*Purpose: Improving the quality of dialysis care for patients with end stage kidney disease (ESKD) is a national clinical and policy priority: the Advancing American…
2021 American Transplant Congress
Accounting for Survivor Bias in Transplant Benefit Models
E. M. Schnellinger¹, E. Cantu², M. O. Harhay¹, D. E. Schaubel¹, S. E. Kimmel¹, A. J. Stephens-Shields¹
¹Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, ²Department of Surgery, Division of Cardiovascular Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA
*Purpose: The lung allocation system in the U.S. prioritizes lung transplant candidates based on estimated pre- and post-transplant survival. However, these models do not account…
2021 American Transplant Congress
Influence of Vitamin D Status on the Prognosis of Covid 19 in Patients with Kidney Transplant
J. Ugalde-Altamirano, I. Revuelta, A. Carrillo, M. Xipell, F. Cofan, N. Esforzado, E. Montagud, G. Piñeiro, A. Molina, P. Ventura, D. Cucchiari, F. Oppenheimer, F. Diekmann, J. Campistol, B. Bayes, J. Torregrosa
Nephrology, Hospital Clinic de Barcelona, Barcelona, Spain
*Purpose: The protective role of Vitamin D as an immunomodulator has been demonstrated in different pathologies included the viral etiology. This effect has been described…
2021 American Transplant Congress
Donor Derived Transmissions 2019: Analysis of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC)
L. Danziger-Isakov¹, M. G. Michaels¹, A. Agarwal¹, S. Aslam¹, K. Dunn¹, J. Goldman¹, D. Levine¹, C. Marboe¹, G. Marklin¹, S. Pouch¹, M. Rana¹, R. Razonable¹, H. L. Stevenson¹, H. S. Te¹, A. Woolley¹, E. Ward², C. Jett², L. Cartwright², R. La Hoz¹
¹OPTN DTAC, Richmond, VA, ²UNOS, Richmond, VA
*Purpose: The OPTN DTAC, a multidisciplinary group, evaluates potential donor derived transmission events (PDDTE), mostly infections (I) & malignancies (M), to assess the likelihood of…
2021 American Transplant Congress
The Gut Microbiome in Heart Transplantation: A Prospective Pilot Study
M. Dela Cruz¹, E. Littmann², R. Nayak², C. Lehmann², R. Keskey³, T. Baker³, H. Lin², A. Bennett¹, G. Kim¹, S. Pinney¹, E. Pamer², A. B. Nguyen¹
¹Cardiology, University of Chicago, Chicago, IL, ²Medicine, University of Chicago, Chicago, IL, ³Surgery, University of Chicago, Chicago, IL
*Purpose: The contribution of the intestinal microbiome to alloimmunity in heart transplantation (HT) is unknown. We examined the fecal microbiota of HT recipients at the…
2021 American Transplant Congress
Renal Transplant Outcomes of Kidney-only vs. Multi-organ Deceased Donors
J. Espinales¹, Z. C. Giffen¹, D. Schneider², R. James³, N. Koizumi³, O. Ekwenna¹, J. Ortiz⁴
¹University of Toledo Medical Center, Toledo, OH, ²UC Irvine School of Medicine, Irvine, CA, ³George Mason University, Arlington, VA, ⁴Albany Medical Center, Albany, NY
*Purpose: We sought to determine the relative outcomes of kidneys from kidney-only or multi-organ deceased donors.*Methods: Scientific Registry of Transplant Recipients data from 2010-2019 were…
2021 American Transplant Congress
Donor Factors Associated with In-field Decline of Heart Allografts
L. Piechura, F. Yazdchi, M. Harloff, H. Shim, M. Keshk, A. Coppolino, III, D. Rinewalt, H. Mallidi
Brigham and Women's Hospital, Boston, MA
*Purpose: The decline of organs upon assessment within the field complicates optimal organ and resource utilization. We aimed to investigate if certain donor factors were…
2021 American Transplant Congress
Profile of SARS-CoV-2 Antibodies in Patients Awaiting Kidney Transplantation
L. Muir¹, A. Jaffer², C. Rees-Spear¹, V. Gopalan², F. Chang², G. Vaitkute¹, R. Fernando³, C. Roustan⁴, A. Rosa⁴, C. Earl⁴, A. Salama², P. Cherepanov⁴, L. E. McCoy¹, R. Motallebzadeh²
¹Institute of Immunity & Transplantation, University College London, London, United Kingdom, ²Nephrology & Transplantation, Royal Free London Hospital NHS Trust, London, United Kingdom, ³Anthony Nolan Institute, Royal Free London Hospital NHS Trust, London, United Kingdom, ⁴The Francis Crick Institute, London, United Kingdom
*Purpose: Patients with end-stage kidney disease (ESKD) represent an extremely vulnerable group with many risk factors for adverse outcomes following SARS-CoV-2 infection. Key questions pertaining…
2021 American Transplant Congress
Risk Factors Predicting Outcomes in Long-Term Pediatric Kidney Transplant Graft Survival
A. Anand, T. H. Malik, J. Dunson, M. F. McDonald, C. R. Christmann, N. Nguyen Galvan, C. O'Mahony, J. A. Goss, P. R. Srivaths, E. D. Brewer, A. Rana
Baylor College of Medicine, Houston, TX
*Purpose: Pediatric kidney transplant recipients generally have good outcomes post-transplantation; however, the younger age and longer lifespan after transplantation in the pediatric population make understanding…
2021 American Transplant Congress
A Randomized, Multicenter, Blinded Study Assessing the Effects of Gaseous Nitric Oxide in an Ex Vivo System of Human Lungs
M. G. Hartwig¹, J. A. Klapper¹, N. Poola², A. Banga³, P. G. Sanchez⁴, J. S. Murala³, J. L. Potenziano²
¹Duke University Medical Center, Durham, NC, ²Mallinckrodt Pharmaceuticals, Bedminster, NJ, ³University of Texas Southwestern Medical Center, Dallas, TX, ⁴University of Pittsburgh Medical Center, Pittsburgh, PA
*Purpose: The effects of nitric oxide (NO) on donor lungs during ex vivo lung perfusion (EVLP) have not been studied. We assessed whether the novel…